$ADIA From Pink Sheets to OTCQB & Beyond! The comp
Post# of 98603

- Higher reporting standards = More transparency
- Increased market visibility = More liquidity
- Stronger investor confidence = More institutional interest
- Nasdaq Small Cap roadmap is now in place!
With a growing stem cell division + this new financial milestone, $ADIA is positioning itself as a serious player in the biotech & health sector. Still a low float stock with massive potential—this up-listing news could be the start of a major move!
https://www.globenewswire.com/news-release/20...l-Cap.html

